350 related articles for article (PubMed ID: 20010493)
41. Considerations for supplementing with coenzyme Q10 during statin therapy.
Levy HB; Kohlhaas HK
Ann Pharmacother; 2006 Feb; 40(2):290-4. PubMed ID: 16449543
[TBL] [Abstract][Full Text] [Related]
42. Increased oxidative stress suggested by low serum vitamin E concentrations in patients with chronic fatigue syndrome.
Miwa K; Fujita M
Int J Cardiol; 2009 Aug; 136(2):238-9. PubMed ID: 18684522
[TBL] [Abstract][Full Text] [Related]
43. Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: comparison between milnacipran and paroxetine.
Ikenouchi-Sugita A; Yoshimura R; Hori H; Umene-Nakano W; Ueda N; Nakamura J
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1451-3. PubMed ID: 19664676
[TBL] [Abstract][Full Text] [Related]
44. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations.
Bhagavan HN; Chopra RK
Mitochondrion; 2007 Jun; 7 Suppl():S78-88. PubMed ID: 17482886
[TBL] [Abstract][Full Text] [Related]
45. Coenzyme Q10 level in plasma of children with inflammatory process.
Mikołuć B; Karpińska J; Motkowski R; Piotrowska-Jastrzebska J
Rocz Akad Med Bialymst; 2002; 47():123-9. PubMed ID: 12533954
[TBL] [Abstract][Full Text] [Related]
46. Coenzyme Q10 in phenylketonuria and mevalonic aciduria.
Hargreaves IP
Mitochondrion; 2007 Jun; 7 Suppl():S175-80. PubMed ID: 17442628
[TBL] [Abstract][Full Text] [Related]
47. Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis / chronic fatigue syndrome.
Maes M; Mihaylova I; Kubera M; Uytterhoeven M; Vrydags N; Bosmans E
Neuro Endocrinol Lett; 2009; 30(6):715-22. PubMed ID: 20035260
[TBL] [Abstract][Full Text] [Related]
48. Plasma coenzyme Q
Svete AN; Verk B; Seliškar A; Tomsič K; Križman PJ; Petrič AD
Am J Vet Res; 2017 Apr; 78(4):447-457. PubMed ID: 28346005
[TBL] [Abstract][Full Text] [Related]
49. Oral coenzyme Q10 supplementation improves clinical symptoms and recovers pathologic alterations in blood mononuclear cells in a fibromyalgia patient.
Cordero MD; Cotán D; del-Pozo-Martín Y; Carrión AM; de Miguel M; Bullón P; Sánchez-Alcazar JA
Nutrition; 2012; 28(11-12):1200-3. PubMed ID: 22898267
[TBL] [Abstract][Full Text] [Related]
50. Coenzyme Q10 concentration in plasma and blood cells of juvenile patients hospitalized for anorexia nervosa.
Niklowitz P; Brosche-Bockholt B; Dieffenbach I; Dieffenbach R; Andler W; Paulussen M; Menke T
Biofactors; 2012; 38(1):53-8. PubMed ID: 22311849
[TBL] [Abstract][Full Text] [Related]
51. The role of coenzyme Q10 in the pathophysiology and therapy of experimental congestive heart failure in the dog.
Harker-Murray AK; Tajik AJ; Ishikura F; Meyer D; Burnett JC; Redfield MM
J Card Fail; 2000 Sep; 6(3):233-42. PubMed ID: 10997750
[TBL] [Abstract][Full Text] [Related]
52. Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID study.
Stocker R; Pollicino C; Gay CA; Nestel P; Colquhoun D; Whiting M; Tonkin A; Sullivan D; Simes J
Atherosclerosis; 2006 Jul; 187(1):198-204. PubMed ID: 16219312
[TBL] [Abstract][Full Text] [Related]
53. Oxidative stress markers in hemodialysis and peritoneal dialysis patients, including coenzyme Q10 and ischemia-modified albumin.
Mehmetoglu I; Yerlikaya FH; Kurban S; Erdem SS; Tonbul Z
Int J Artif Organs; 2012 Mar; 35(3):226-32. PubMed ID: 22461118
[TBL] [Abstract][Full Text] [Related]
54. Recent Developments in the Role of Coenzyme Q10 for Coronary Heart Disease: a Systematic Review.
Ayers J; Cook J; Koenig RA; Sisson EM; Dixon DL
Curr Atheroscler Rep; 2018 May; 20(6):29. PubMed ID: 29766349
[TBL] [Abstract][Full Text] [Related]
55. Coenzyme Q10 concentrations in coronary artery disease.
Yalcin A; Kilinc E; Sagcan A; Kultursay H
Clin Biochem; 2004 Aug; 37(8):706-9. PubMed ID: 15302616
[TBL] [Abstract][Full Text] [Related]
56. Low circulating coenzyme Q10 during acute phase is associated with inflammation, malnutrition, and in-hospital mortality in patients admitted to the coronary care unit.
Shimizu M; Miyazaki T; Takagi A; Sugita Y; Yatsu S; Murata A; Kato T; Suda S; Ouchi S; Aikawa T; Hiki M; Takahashi S; Hiki M; Hayashi H; Kasai T; Shimada K; Miyauchi K; Daida H
Heart Vessels; 2017 Jun; 32(6):668-673. PubMed ID: 27942805
[TBL] [Abstract][Full Text] [Related]
57. Attenuation of autoimmune responses to oxidative specific epitopes, but not nitroso-adducts, is associated with a better clinical outcome in Myalgic Encephalomyelitis/chronic fatigue syndrome.
Maes M; Leunis JC
Neuro Endocrinol Lett; 2014; 35(7):577-85. PubMed ID: 25617880
[TBL] [Abstract][Full Text] [Related]
58. Endogenous plasma coenzyme Q10 concentration does not correlate with plasma total antioxidant capacity level in healthy untrained horses.
Bohar Topolovec M; Kruljc P; Prošek M; Jazbec Križman P; Smidovnik A; Nemec Svete A
Res Vet Sci; 2013 Oct; 95(2):675-7. PubMed ID: 23648076
[TBL] [Abstract][Full Text] [Related]
59. Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome?
Castro-Marrero J; Cordero MD; Segundo MJ; Sáez-Francàs N; Calvo N; Román-Malo L; Aliste L; Fernández de Sevilla T; Alegre J
Antioxid Redox Signal; 2015 Mar; 22(8):679-85. PubMed ID: 25386668
[TBL] [Abstract][Full Text] [Related]
60. Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome - A randomized, controlled, double-blind trial.
Castro-Marrero J; Sáez-Francàs N; Segundo MJ; Calvo N; Faro M; Aliste L; Fernández de Sevilla T; Alegre J
Clin Nutr; 2016 Aug; 35(4):826-34. PubMed ID: 26212172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
